Healthcare Experts Are Skeptical About Amazon, JPMorgan, and Berkshire Hathaway’s New Venture
25th April 2018
The venture, announced in January, is aimed at lowering healthcare costs for the companies’ employees, though there haven’t been many details about what that looks like. At the time, news of the partnership sent healthcare stocks plummeting, especially health insurers and members of the pharmaceutical supply chain who might be impacted by the three business giants getting into their lines of work.
But those who have been in the healthcare industry for a while are skeptical of the speed at which the venture could potentially threaten existing healthcare companies. Of the 300 healthcare professionals, large employers, investors, and academics surveyed by venture capital firm Venrock, 73% thought that it’s going to take a lot longer than expected and face many challenges.
In particular, 25% of those surveyed said that the companies “have no idea what they’re getting into.”